SARS-CoV-2 infection in patients with sickle cell disease.
作者信息
Argüello-Marina María, López-Rubio Montserrat, Morado Marta
机构信息
Hospital U. Príncipe de Asturias, Madrid, España.
Hospital U. Príncipe de Asturias, Madrid, España.
出版信息
Med Clin (Barc). 2021 Oct 8;157(7):345-346. doi: 10.1016/j.medcli.2021.03.033. Epub 2021 May 11.
Abstract
摘要
相似文献
1
SARS-CoV-2 infection in patients with sickle cell disease.镰状细胞病患者的新型冠状病毒2型感染
Med Clin (Barc). 2021 Oct 8;157(7):345-346. doi: 10.1016/j.medcli.2021.03.033. Epub 2021 May 11.
2
Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: A 12-month prospective cohort study.患有疼痛危象的镰状细胞病患者中SARS-CoV-2感染的发生率：一项为期12个月的前瞻性队列研究。
Int J Lab Hematol. 2022 Apr;44(2):e87-e90. doi: 10.1111/ijlh.13739. Epub 2021 Oct 15.
3
Selenium supplementation may improve COVID-19 survival in sickle cell disease.补硒可能改善镰状细胞病 COVID-19 患者的存活率。
Br J Nutr. 2022 Aug 28;128(4):778-779. doi: 10.1017/S0007114521003718. Epub 2021 Sep 17.
4
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
5
COVID-19 and sickle cell disease in Bahrain.巴林的 COVID-19 和镰状细胞病。
Int J Infect Dis. 2020 Dec;101:14-16. doi: 10.1016/j.ijid.2020.09.1433. Epub 2020 Sep 24.
6
COVID -19 Precipitating Vaso-Occlusive Crisis in a Patient of Sickle Cell Anemia with Avascular Necrosis of Femur.新冠病毒肺炎引发一名患有镰状细胞贫血合并股骨头缺血性坏死患者的血管闭塞危象
J Assoc Physicians India. 2022 Dec;69(12):11-12.
7
Teaching Implicit Bias and Its Management in the Pain Care of Sickle Cell Anemia Patients in a Hyflex Pre-Professional Classroom During COVID-19.在 COVID-19 期间，于混合式预专业课堂中教授镰状细胞贫血患者疼痛护理中的隐性偏见及其管理
Pain Med. 2022 Mar 2;23(3):435-439. doi: 10.1093/pm/pnab340.
8
Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination.一名患有镰状细胞病的青少年在接种新冠疫苗后出现血小板减少症。
Pediatr Blood Cancer. 2021 Dec;68(12):e29271. doi: 10.1002/pbc.29271. Epub 2021 Jul 31.
9
Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.管理新冠病毒感染的镰状细胞病患者：汇聚我们集体经验的必要性。
Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.
10
Comment on: Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination.关于：一名患有镰状细胞病的青少年在接种新冠疫苗后出现血小板减少症的评论。
Pediatr Blood Cancer. 2022 Jan;69(1):e29303. doi: 10.1002/pbc.29303. Epub 2021 Aug 19.
引用本文的文献
1
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.红细胞疾病患者中的新型冠状病毒肺炎，来自欧洲登记处ERN-EuroBloodNet的结果
Orphanet J Rare Dis. 2025 Apr 16;20(1):183. doi: 10.1186/s13023-025-03683-7.
本文引用的文献
1
Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience.镰状细胞病患者感染新冠病毒后的低发病率和死亡率：单中心经验
EJHaem. 2020 Aug 30;1(2):608-614. doi: 10.1002/jha2.87. eCollection 2020 Nov.
2
COVID-19 and sickle cell disease in Bahrain.巴林的 COVID-19 和镰状细胞病。
Int J Infect Dis. 2020 Dec;101:14-16. doi: 10.1016/j.ijid.2020.09.1433. Epub 2020 Sep 24.
3
Prognosis of patients with sickle cell disease and COVID-19: a French experience.镰状细胞病患者与新冠病毒病的预后：法国的经验
Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18.
4
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
Zotero 插件